# Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies

> **NCT04265573** · — · COMPLETED · sponsor: **Groupe de Recherche Action en Sante** · enrollment: 150000 (actual)

## Conditions studied

- Malaria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04265573
- **Lead sponsor:** Groupe de Recherche Action en Sante
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-10
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-02-25
- **Target enrollment:** 150000 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04265573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04265573, "Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04265573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*